Trust Point Inc’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,551
Closed -$685K 523
2026
Q1
$685K Sell
8,551
-190
-2% -$15.7K 0.06% 175
2025
Q4
$745K Sell
8,741
-95
-1% -$7.8K 0.06% 162
2025
Q3
$687K Buy
+8,836
New +$690K 0.06% 164
2025
Q2
Sell
-8,780
Closed -$636K 437
2025
Q1
$636K Sell
8,780
-582
-6% -$41.7K 0.06% 178
2024
Q4
$693K Sell
9,362
-1,622
-15% -$114K 0.05% 222
2024
Q3
$725K Sell
10,984
-548
-5% -$39.8K 0.05% 213
2024
Q2
$1.07M Sell
11,532
-419
-4% -$37.1K 0.09% 139
2024
Q1
$1.14M Buy
11,951
+599
+5% +$50.3K 0.09% 131
2023
Q4
$866K Buy
+11,352
New +$790K 0.07% 159

Other funds holding EW

Trust Point Inc's EW Position: Q2 2026 in Review

Trust Point Inc sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 8,551 shares — an estimated $685K sold.

Trust Point Inc first reported a position in EW in Q4 2023 and held it in 9 quarters. The position peaked at $1.14M in Q1 2024. 326 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Trust Point Inc reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Trust Point Inc sold 8,551 Edwards Lifesciences shares in Q2 2026, an estimated $685K.
  • Trust Point Inc first reported a position in Edwards Lifesciences in Q4 2023 and held it in 9 quarters.
  • Trust Point Inc's Edwards Lifesciences position peaked at $1.14M in Q1 2024.
  • 326 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.